Lenskart Solutions IPO

Lenskart Solutions Limited is a technology-driven eyewear company engaged in designing, manufacturing, branding, and retailing of prescription eyeglasses, sunglasses, and contact lenses. It is India’s largest seller of prescription eyeglasses by volume in FY25 and among the top two organised eyewear retailers in Asia in terms of B2C eyeglasses sales. With over 2,723 stores globally, including 2,067 in India and 656 internationally, the company operates through an omnichannel model integrating its online platform and offline retail presence.

The company manufactured nearly 70% of prescription eyeglasses sold by it during FY25 through its centralised manufacturing facilities in Bhiwadi and Gurugram, in addition to its facilities in Singapore and the UAE. The Bhiwandi facility is among the top 2 globally in terms of capacity, with 75% automation. Having expanded internationally since 2019 and acquired Japan and Southeast Asia-based Owndays in 2022, Lenskart now has a strong presence in Southeast Asia and the Middle East. In FY25, the company sold 2.29 crore eyewear units in India and 0.43 crore units internationally. In FY25, it conducted approximately 1.34 crore eye tests in India and 0.26 crore eye tests outside India, which was the highest number of eye tests among leading organised prescription eyeglasses retailers in India.

The company received SEBI approval for the IPO in October 2025. The IPO is a bookbuilding issue consisting of a fresh issue of shares up to ₹2,150 crore and an offer for sale of over 13 crore shares by existing shareholders. The total issue size is expected to be around ₹8,000 crore. The book-running lead managers include Kotak Mahindra Capital Company Limited, Morgan Stanley India Company Private Limited, Avendus Capital Private Limited, Citigroup Global Markets India Private Limited, Axis Capital Limited and Intensive Fiscal Services Private Limited.